XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - ValueSet, Authority Hl7

17,881 resources

By Version

R2: 0
R2B: 0
R3: 631
R4: 13,619
R4B: 220
R5: 3,383
R6: 28

By Realm

none: 802
au: 53
be: 108
ca: 49
ch: 389
cl: 150
cr: 11
cz: 48
de: 50
dk: 21
ee: 55
eu: 308
fi: 4
fr: 38
it: 92
nl: 402
no: 6
nz: 17
pl: 23
se: 10
us: 11,158
uv: 4,022
vn: 23
other: 5

Start Prev Rows 6400 - 6600 Next

Package	Version	Identity	Name/Title	Status	FMM	WG	Date	Realm
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1499	Medications for Below Normal BMI	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1519	Follow Up for Above Normal BMI	active			2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1523	Follow Up for Above Normal BMI	active			2017-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1524	Follow Up for BMI Outside Normal Parameters	active			2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1525	Follow Up for Above Normal BMI	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1526	Follow Up for Above Normal BMI	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1527	Referrals Where Weight Assessment May Occur	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1528	Follow Up for Below Normal BMI	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1549	Follow Up for Below Normal BMI	active			2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1550	Follow Up for Below Normal BMI	active			2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1551	Follow Up for Below Normal BMI	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1578	Palliative Care	active			2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1579	Palliative or Hospice Care	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1608	Encounter to Document Medications	active			2025-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1609	Encounter to Document Medications	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1610	Referrals Where Weight Assessment May Occur	active			2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1751	Encounter to Evaluate BMI	active			2024-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1834	Encounter to Document Medications	active			2024-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1917	Encounter to Document Medications	active			2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.695	Encounter to Evaluate BMI	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.885	Encounter to Evaluate BMI	active			2018-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.886	Encounter to Evaluate BMI	active			2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1475	Referral to Primary Care or Alternate Provider	active			2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1476	Pharmacologic Therapy for Hypertension	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1482	Laboratory Tests for Hypertension	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1497	Encounter to Screen for Blood Pressure	active			2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1508	Lifestyle Recommendation	active			2025-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1509	Weight Reduction Recommended	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1510	Weight Reduction Recommended	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1511	Dietary Recommendations	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1512	Dietary Recommendations	active			2025-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1514	Dietary Recommendations	active			2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1515	Dietary Recommendations	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1516	Exercise Class	active			2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1518	Recommendation to Increase Physical Activity	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1537	Follow Up Within 4 Weeks	active			2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1538	Encounter to Screen for Depression	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1914	Encounter to Screen for Depression	active			2020-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1915	Encounter to Screen for Depression	active			2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1916	Encounter to Screen for Depression	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1918	Encounter to Screen for Blood Pressure	active			2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.192	Encounter to Screen for Blood Pressure	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1920	Encounter to Screen for Blood Pressure	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2387	Overweight or Obese	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2388	Underweight	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2395	Finding of Hypertension	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2462	Laboratory Tests for Hypertension	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2466	Dental Tooth Extraction	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.259	Diagnosis of Hypertension	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.261	Diagnosis of Hypertension	active			2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.263	Diagnosis of Hypertension	active			2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.467	Follow Up for Adolescent Depression	active			2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.468	Follow Up for Adult Depression	active			2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.469	Adolescent Depression Medications	active			2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.470	Adult Depression Medications	active			2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.537	Referral for Adolescent Depression	active			2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.538	Referral for Adult Depression	active			2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.791	Patient Declined	active			2025-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.805	Weight Reduction Recommended	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.810	Recommendation to Increase Physical Activity	active			2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.823	Referral or Counseling for Alcohol Consumption	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.6366.117	Absence of Cervix	active			2024-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.1743	General or Neuraxial Anesthesia	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.1940	Immunocompromised Conditions	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.2262	CABG Surgeries	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.2328	Immunocompromised Conditions I10	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.2343	Immunocompromised Conditions	active			2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.3011	Acute Myocardial Infarction	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.3024	Acute Myocardial Infarction	active			2016-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.307	Encounter Inpatient	active			2020-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.335	Bone Marrow Transplant	active			2021-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.336	Bone Marrow Transplant	active			2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.404	Bone Marrow Transplant	active			2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.623	Acute Myocardial Infarction	active			2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.694	CABG Surgeries	active			2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.737	PCI	active			2018-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.747	Endotracheal Intubation	active			2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.128	Bipolar Disorder	active			2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.246	Personality Disorder Emotionally Labile	active			2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.247	Personality Disorder Emotionally Labile	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.248	Personality Disorder Emotionally Labile	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.249	Personality Disorder Emotionally Labile	active			2023-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.254	Dysthymia	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.256	Dysthymia	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.257	Dysthymia	active			2023-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.262	Deceased	active			2014-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.263	PHQ 9 and PHQ 9M Tools	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.269	Hepatitis B	active			2017-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.271	Hepatitis B	active			2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.272	Hepatitis B	active			2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.43	Bipolar Disorder	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.44	Bipolar Disorder	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.45	Bipolar Disorder	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.11.721	Deceased	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.11.723	PHQ-9 Tool	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.6929.2.1000	Estimated Glomerular Filtration Rate	active			2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.6929.2.1002	Urine Albumin Creatinine Ratio	active			2025-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.6929.3.1000	Estimated Glomerular Filtration Rate	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.6929.3.1007	Urine Albumin Creatinine Ratio	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1000	Strabismic Amblyopia	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1001	Strabismic Amblyopia	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1002	Refractive Amblyopia	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1003	Refractive Amblyopia	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1004	Routine Ophthalmological Examination	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1005	Pediatric Best Corrected Visual Acuity Exam	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1006	LogMAR Visual Acuity Exam	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1007	Aphakia	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1008	Aphakia	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1009	Infantile and Juvenile Cataract	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1010	Infantile and Juvenile Cataract	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1011	Congenital Corneal or Anterior Segment Conditions	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1012	Congenital Corneal or Anterior Segment Conditions	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1013	Eyelid or Orbital Conditions	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1014	Eyelid or Orbital Conditions	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1015	Coloboma of Optic Disc	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1016	Coloboma of Optic Disc	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1017	Hemorrhage of Optic Nerve Sheath	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1018	Hemorrhage of Optic Nerve Sheath	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1019	Optic Nerve Hypoplasia	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1020	Optic Nerve Hypoplasia	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1021	Disorder of Visual Cortex Due to Underlying Condition	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1022	Disorder of Visual Cortex Due to Underlying Condition	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1023	Cortical Blindness	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1024	Cortical Blindness	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1025	Congenital Condition of Retina	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1026	Congenital Condition of Retina	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1000	Strabismic Amblyopia	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1001	Refractive Amblyopia	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1002	Routine Ophthalmological Examination	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1003	Pediatric Best Corrected Visual Acuity Exam	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1004	LogMAR Visual Acuity Exam	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1005	Aphakia	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1006	Infantile and Juvenile Cataract	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1007	Congenital Corneal or Anterior Segment Conditions	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1008	Eyelid or Orbital Conditions	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1009	Coloboma of Optic Disc	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1010	Hemorrhage of Optic Nerve Sheath	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1011	Optic Nerve Hypoplasia	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1012	Disorder of Visual Cortex Due to Underlying Condition	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1013	Cortical Blindness	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1014	Congenital Condition of Retina	active			2019-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.88.12.3221.6.2	Allergy and Intolerance Type	active			2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.88.12.3221.7.2	Problem Type (SNOMEDCT)	active			2025-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.88.12.3221.8.7	SPL Drug Route of Administration Terminology	active			2024-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.88.12.80.62	Vital Sign Result Type	active			2024-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3180	NHSNInsertionSiteCode	active			2020-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3181	NHSNRoleOfPerformerCode	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3182	NHSNReasonForInsertionCode	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3183	NHSNSkinPreparationCode	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3184	NHSNSterileBarrierCode	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3185	NHSNCatheterTypeCode	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3194	NHSNSignificantPathogenCode	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3195	NHSNCriterionOfDiagnosisCode	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3196	NHSNInfectionConditionCode	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3234	NHSNPopulationCategoryCode	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3247	NHSNTimingCode	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3248	NHSNEligibilityCode	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3249	NHSNSpecimenTypeCode	active			2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3283	NHSNOrganismASTCode	active			2020-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3360	NHSNAntimicrobialAgentAURPCode	active			2025-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3361	NHSNRouteOfAdministrationAURPCode	active			2020-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3595	NHSNPopulationSummaryReportTypeCode	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.6007	NHSNVascularAccessTypeCode	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.6008	NHSNSuspectedSourceTypeCode	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.6042	NHSNVascularAccessSiteCode	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.6051	NHSNClosureTechniqueCode	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.6074	NHSNStaphAureusTestResults	active			2020-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.7160	NHSNStaphAureusSpecificTest	active			2020-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.7214	NHSNSameDayOutcomeMeasure	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.7215	NHSNInfectionFirstReportedSource	active			2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.7232	NHSNRaceCategory	active			2020-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.7233	NHSNPreviousPatientLocation	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.7237	NHSNBloodCollectionLocation	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.7238	NHSNPreviousFacility	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.7239	NHSNContraindicationType	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.7240	NHSNCarbaTestMethod	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.7241	NHSNCarbaDetectType	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.7242	NHSNCdiffTestMethod	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.7338	NHSNStartOrContinuation	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.7353	NHSNSummaryBloodProductUsage	active			2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.836	Race	active			2012-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.837	Ethnicity	active			2012-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.877	Detailed Ethnicity	active			2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.113883.3.67.1.101.3.2444	Major Depression Including Remission	active			2021-02	us
ca.ab.fhir.psab	R4	ValueSet/febd1976-2524-44ea-b31c-633d1329d76e	v3.ConfidentialityClassification-AB-PS	draft				ca
hl7.terminology	R5	ValueSet/v3-RoleCode	v3 Code System RoleCode	active	0	vocab	2018-08	uv
hl7.terminology	R5	ValueSet/v3-ActReason	v3 Code System ActReason	active	1	vocab	2018-08	uv
hl7.terminology	R5	ValueSet/v3-ActSite	v3 Value Set ActSite	active			2018-08	uv
hl7.eu.fhir.pcsp	R4	ValueSet/morphologicAbnormality-eu-vs	Morphologically abnormal structure	draft			2025-08	eu
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1222.140	Ferritin	active			2024-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1005	Rheumatoid Arthritis	active			2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1080	Rheumatoid Arthritis	active			2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1081	Rheumatoid Arthritis	active			2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1222.1428	Myalgia	active			2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1222.1439	Vomiting	active			2024-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1222.1525	Cognitive disorder Diagnosis ICD10	active			2024-06	us
hl7.terminology	R5	ValueSet/v3-ChronicCareFacility	ChronicCareFacility	active			2014-03	uv
hl7.fhir.us.ccda	R4	ValueSet/2.16.840.1.113883.11.20.4.1	DischargeSummaryDocumentTypeCode	trial-use		cgp	2025-07	us
hl7.fhir.us.ccda	R4	ValueSet/2.16.840.1.113883.1.11.20.22	HPDocumentType	trial-use		cgp	2025-07	us
hl7.fhir.us.ccda	R4	ValueSet/2.16.840.1.113762.1.4.1099.10	Care Plan Document Type	trial-use		cgp	2025-07	us